Hm. Cox et Ir. Tough, CALCITONIN-GENE-RELATED PEPTIDE RECEPTORS IN HUMAN GASTROINTESTINAL EPITHELIA, British Journal of Pharmacology, 113(4), 1994, pp. 1243-1248
1 The secretory responses to calcitonin gene-related peptide (CGRP) re
ceptor agonists have been characterized in two human adenocarcinoma ce
ll lines, namely HCA-7 and Colony-29 (Col-29) epithelia. These cells f
orm polarized epithelial layers when grown on permeable supports and a
llow changes in electrogenic ion transport in response to agonists to
be monitored continuously. 2 alpha-CGRP (rat and human sequences), rat
beta-CGRP and human [Tyr(0)]CGRP applied to the basolateral surface w
ere found to be full agonists, causing prolonged increases in short-ci
rcuit current. Concentration-response curves exhibited EC(50) values o
f 0.6-1.5 nM in HCA-7 cells. The same agonists were less effective in
Col-29 epithelia, the EC(50) values ranging from 1 to 10 nM in these c
ells. [Cys(ACM)2,7]CGRP was effective in both cell lines and was more
potent in HCA-7 cells. 3 CGRP receptors were preferentially located on
the basolateral surface in both cell types. Addition of r alpha-CGRP
to the apical domain produced significantly smaller secretory response
s (8.1% in HCA-7 and 29.2% in Col-29) compared with those produced fol
lowing basolateral application (100%). 4 In both cell lines r alpha-CG
RP-elevated short-circuit current was inhibited by the loop diuretic p
iretanide (200 mu M) and by somatostatin (100 nM). Pretreating epithel
ia with the cyclo-oxygenase inhibitor, piroxicam (5 mu M) had no signi
ficant effect upon CGRP responses in either cell line. 5 Rat alpha-CGR
P (0.2 nM) responses in HCA-7 epithelia were inhibited by the C-termin
al fragment CGRP(8-37) (1 mu M). Pretreatment of Col-29 cells with CGR
P(8-37) did not, however, alter the size or profile of responses to r
alpha-CGRP (1 nM). 6 We conclude that high-affinity CGRP receptors exi
st on the basolateral surface of both cell lines, however they differ
in their sensitivity to CGRP(8-37) and agonist orders of potency. Thus
different CGRP receptor subtypes appear to predominate in these two e
pithelial cell types.